Temozolomide as a Prophylaxis Against Brain Recurrence in Participants With Metastatic Breast Cancer (P05225 AM2)
Status:
Terminated
Trial end date:
2010-06-30
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether temozolomide can be used as a prophylaxis
against brain recurrence in participants with metastatic breast cancer.